Clin2
NCT07187011Possibly a fitNot yet recruiting

Testing PT150 for PTSD in veterans

PTSD - Post Traumatic Stress Disorder

Part of Injuries & trauma, Mental health clinical trials.

This trial tests a new oral medication, PT150, to see if it helps reduce PTSD symptoms in veterans. You must have had PTSD for at least 3 months and not be taking certain other medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a military service member or veteran aged 18–65.
  • You have been diagnosed with PTSD for at least 3 months.
  • You are not currently taking certain medications (like benzodiazepines or strong sleep aids) and have been on SSRI/SNRI antidepressants for more than 30 days if you take them.
  • You do not have severe alcohol or drug problems in the past 3 months (except cannabis).
  • You are not pregnant, nursing, or have a serious medical condition like heart, liver, or kidney disease.
  • You are willing to take daily oral medication and attend all study visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07777380Not yet recruiting· Phase 2
Brain stimulation for veterans with post-traumatic stress disorder

This study tests a type of brain stimulation called TMS combined with a medication called D-cycloserine to see if it helps reduce PTSD symptoms in military veterans. It may offer a new treatment option for those who haven't found relief from standard therapies.

Vancouver, British Columbia
NCT06852469Recruiting· Phase 4
GABA test for PTSD in veterans

This trial uses a medication called lorazepam to study how GABA receptors work in veterans with PTSD. It aims to learn more about brain chemistry related to PTSD and how it might affect treatment.

San Diego, California
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT07499440Recruiting· Phase 2
Testing a new medicine, HB-1, for PTSD

This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.

Bruce, Australian Capital Territory
NCT06381180Recruiting· Phase 1/Phase 2
Cannabis for Veterans with PTSD

This study is testing whether cannabis can help veterans with PTSD feel better. It is for veterans who have used cannabis before and currently have PTSD symptoms.

Detroit, Michigan
NCT07224698Not yet recruiting· Phase 2
Inhaled cannabis for treating PTSD

This study tests whether inhaled cannabis can help reduce PTSD symptoms in veterans. You will receive cannabis provided by the study team and be monitored over several weeks.

Hear when a new PTSD - Post Traumatic Stress Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.